相关产品推荐更多 >

RTN4IP1 MaxPab小鼠源多克隆抗体(B01) | RTN4IP1 MaxPab mouse polyclonal antibody (B01)
询价
ABCC10 抗体-ABCC10 Antibody
¥22
Phosphothreonine 抗体:偶联ATTO 488|Phosphothreonine Antibody: ATTO 488
询价
PacBlue Anti-human CD3 Antibody *SK7*/PacBlue Anti-human CD3 Antibody *SK7*/PacBlue Anti-human CD3 Antibody *SK7*
询价
SFRS12IP1 抗体-SFRS12IP1 Antibody
¥22
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Adenosine A2a Receptor monoclonal antibody was raised against 6His - tagged 3rd Cytoplasmic Domain human recombinant Adenosine A2a receptor (Human).
- 保存条件:
Short term: 4℃
- 保质期:
1年
- 级别:
科研级别
- 库存:
100
- 供应商:
艾美捷科技
- 宿主:
小鼠
- 应用范围:
WB, IHC, Flow
- 抗体英文名:
Adenosine A2a Receptor Antibody [7F6-G5-A2 / 7F6]
- 抗体名:
Adenosine A2a Receptor Antibody [7F6-G5-A2 / 7F6]
- 规格:
0.05mg
Adenosine A2a Receptor 抗体 [7F6-G5-A2 / 7F6],Adenosine A2a Receptor Antibody [7F6-G5-A2 / 7F6],Adenosine A2a Receptor 抗体 [7F6-G5-A2 / 7F6],Adenosine A2a Receptor Antibody [7F6-G5-A2 / 7F6]
产品名称:Adenosine A2a Receptor 抗体 [7F6-G5-A2 / 7F6]-Adenosine A2a Receptor Antibody [7F6-G5-A2 / 7F6]
产品货号:PSI-49-998-0.05mg
产品规格:0.05mg
背景资料:Adenosine A2a Receptor Antibody [7F6-G5-A2 / 7F6]
保存建议:Adenosine A2a Receptor 抗体 [7F6-G5-A2 / 7F6]-Adenosine A2a Receptor Antibody [7F6-G5-A2 / 7F6]Short term: 4℃
应用类型:WB, IHC, Flow
点击:Adenosine A2a Receptor 抗体 [7F6-G5-A2 / 7F6]-Adenosine A2a Receptor Antibody [7F6-G5-A2 / 7F6]查看更详细产品说明,更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多ProSci公司特色试剂盒、特色抗体以及特色试剂等产品评论,请点击查看艾美捷特色产品中心。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验For quite some time, the majority of GPCR models have been based on a single template structure: dark-adapted bovine rhodopsin. The recent solution of β2AR, β1AR and adenosine A2A receptor crystal structures has dramatically expanded the GPCR
Characterization of P1 (Adenosine) Purinoceptors
in both the mammalian CNS and peripheral tissues. Four ADO receptor subtypes have been cloned and characterized. Described in this unit are three radioligand binding assays for pharmacological characterization of the high?affinity ADO receptor subtypes A1 , A2A , and A3
Detection of Receptor Heteromers Involving Dopamine Receptors by the Sequential BRET-FRET Technology
to be identified. In SRET experiments, the oxidation of a Renilla Luciferase substrate triggers acceptor excitation by BRET and subsequent energy transfer to a FRET acceptor. Using this methodology here we describe the heteromerization between adenosine A2A
技术资料暂无技术资料 索取技术资料






